Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA StudyMaggie Banys‐Paluchowski, Geeta Kadayaprath, Elmar Stickeler et al.|Cancers|2021Cited by 159
False-negative rate in the extended prospective TATTOO trial evaluating targeted axillary dissection by carbon tattooing in clinically node-positive breast cancer patients receiving neoadjuvant systemic therapyJana de Boniface, Steffi Hartmann, Karin Dembrower et al.|Breast Cancer Research and Treatment|2022Cited by 31